Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Diamine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101941971B details a green synthesis of Evodiamine via catalytic hydrogenation and anhydride condensation, offering high purity and cost reduction for pharma manufacturing.
Patent CN110066233B details a high-yield cyclization method for mono-substituted amines, offering significant cost reduction in API manufacturing and superior impurity control.
Patent CN108276300B reveals a copper-catalyzed route for high-purity biphenyl triarylamine hole transport materials, offering significant cost reduction and scalability.
Novel bis-evodiamine derivatives with enhanced antitumor activity and scalable synthesis routes for pharmaceutical intermediates supply chain optimization.
Discover a novel metal-free synthesis method for o-diamine compounds via alkenylsulfonium salts. Achieve cost reduction in API manufacturing with scalable, green chemistry.
Patent CN114940657B reveals metal-free light-induced amidine synthesis. Enables cost reduction and high-purity pharmaceutical intermediates manufacturing with scalable green chemistry.
Patent CN110092786B introduces a novel catalytic method for evodiamine synthesis enabling high-yield production through streamlined reaction sequences and enhanced supply chain reliability for pharmaceutical intermediates manufacturing.
Innovative synthesis of axial chirality vicinal diamines with simplified process, cost-effective raw materials, and scalable production for pharmaceutical intermediates supply chain optimization.
Patent CN102276376B introduces an efficient synthesis route eliminating chiral resolution, enhancing purity and reducing supply chain costs for pharmaceutical intermediates.
97% ee, >95% yield, low-cost industrial production of chiral alpha-hydroxy-beta-keto esters for agrochemicals. Solve supply chain risks with scalable zirconium catalysis.
Solve chiral induction challenges with 97% yield axial diamine synthesis. Reduce R&D costs & scale production for pharma intermediates.
Discover a metal-free, high-yield method for chiral 1,3-diamine with >97:3 dr. Reduce costs and supply chain risks in pharmaceutical synthesis.
Struggling with low yield in chiral NHC catalysis? Discover emerging ethylenediamine-based NHC precursor salts for high enantioselectivity. Find reliable suppliers for custom synthesis.